FINNENCE ▪ THE WIRE FILE
THE WIRE · № 59504
News■ Unclear/unknown
Brainomix Announces New Phase III INBUILD® Data Highlighting Potential of Quantitative CT to Predict Disease Progression and Assess Treatment Response in Progressive Pulmonary Fibrosis
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-01 11:00 UTC
LAST UPDATE2026-10-01 11:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Phase III sub-study data supports quantitative CT as a progression predictor; Brainomix is private.
Imaging biomarker evidence, no listed issuer
CATALYST TO WATCH
Regulatory or pharma partnerships
MAIN RISK
Single sub-study; needs broader validation
FULL DISPATCH
Published in the American Journal of Respiratory & Critical Care Medicine (AJRCCM), the analysis of 474 patients from Boehringer Ingelheim's Phase III INBUILD® HRCT sub-study represents the largest prospective evaluation of quantitative CT in patients with progressive pulmonary fibrosis...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care2026-10-01 11:00 UTC
Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care2026-10-01 11:00 UTC
→CORRELATIONshares Healthcare
Innovative Health Launches First Reprocessing Performance Benchmark for Electrophysiology Programs2026-10-01 11:00 UTC
Innovative Health Launches First Reprocessing Performance Benchmark for Electrophysiology Programs2026-10-01 11:00 UTC
→CORRELATIONshares Healthcare
Attilio Hosts Top Scientists From Stanford, Harvard, and Buck Institute at Inaugural Event2026-10-01 11:00 UTC
Attilio Hosts Top Scientists From Stanford, Harvard, and Buck Institute at Inaugural Event2026-10-01 11:00 UTC
→CORRELATIONshares Healthcare
Avanos Medical, Inc. Launches Game Ready® Over-the-Counter Recovery System in the U.S.2026-10-01 11:00 UTC
Avanos Medical, Inc. Launches Game Ready® Over-the-Counter Recovery System in the U.S.2026-10-01 11:00 UTC
→CORRELATIONshares Healthcare
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases2026-10-01 11:17 UTC
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases2026-10-01 11:17 UTC
→CORRELATIONshares Healthcare
Anchor Health Properties Names Joseph E. Link Chief Investment Officer2026-10-01 11:21 UTC
Anchor Health Properties Names Joseph E. Link Chief Investment Officer2026-10-01 11:21 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.